Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
It is the exact same playbook every quarter. They trot out the transformation slide deck, talk about lean operations, and then act surprised when morale hits rock bottom. The reality is that the people left behind are just expected to do the work of three former colleagues without any change in expectations. It’s not a strategy, it’s just budget engineering designed to pump the stock price at the expense of our mental health and institutional knowledge. I am completely burnt out on these hollow corporate slogans.
I understand the frustration, but honestly, this is just the nature of Big Pharma these days. Every major player in the space is chasing efficiency to cover for pipeline gaps or patent cliffs. While the buzzwords are definitely annoying, focusing on the terminology misses the bigger picture of where the industry is heading. It’s a grind, and it’s uncomfortable, but acting like BMS is unique in this cycle is ignoring the broader market reality. We need to stop taking the marketing speak personally and just focus on securing our own exits or next steps.